feba4ef3_g_Antibody___ARUP_Laboratories__Fluid_phase_RIA
[0] in vivo relevance to the drug's capacity to inhibit TNF in patient High [ELISA (solid-phase bridging)] Low Moderate [Fluid-phase RIA] 
Moderate
B i n d i n g
M o d e r a t e
N o
Y e s
L o w
Infliximab Activity & Neutralizing Antibody | ARUP Laboratories
Fluid-phase RIA